Magnesium%25252525252525252525252525252525252525252525252525252520sulphate

# Magnesium Sulphate ## Overview Magnesium sulphate is an essential mineral that plays a crucial role in numerous biochemical processes. It is available in intravenous and intramuscular formulations. ## Primary Indications * **Eclampsia and severe pre-eclampsia:** To prevent seizures. * **Torsades de Pointes:** To treat or prevent polymorphic ventricular tachycardia. * **Hypomagnesemia:** To correct low magnesium levels. * **Bronchodilator:** As an adjunct in severe asthma exacerbations. ## Adult Dosing * **Eclampsia/Severe Pre-eclampsia:** * **Loading dose:** 4-6 grams IV infusion over 15-30 minutes. * **Maintenance dose:** 1-2 grams per hour IV infusion. May be given IM in divided doses (e.g., 5g IM every 4 hours for 24 hours) if IV access is limited or for postpartum prophylaxis, though IV is preferred. Maximum dose generally not specified but should be guided by clinical response and magnesium levels. * **Torsades de Pointes:** * **Acute management:** 1-2 grams IV bolus, followed by an infusion of 0.5-1 gram per hour. Dosing may be repeated as needed. * **Hypomagnesemia:** * **Symptomatic:** 1-4 grams IV infusion over 5-60 minutes. Higher doses may be required for severe deficiency, guided by serum magnesium levels. * **Asymptomatic:** 1 gram IM every 6 hours for 4 doses, or 1-2 grams IV infusion over several hours. * **Asthma (Severe Exacerbations):** 1-2 grams IV infusion over 15-30 minutes. ## Pediatric Dosing * **Eclampsia/Severe Pre-eclampsia (off-label use):** Dosing is highly variable and often guided by institutional protocols. A common regimen is a loading dose of 40 mg/kg IV (maximum 4g) followed by a maintenance infusion of 0.5-1 g/kg/hr (maximum 40 g/day). * **Torsades de Pointes:** 25-100 mg/kg IV (maximum 2 grams) as a bolus, followed by an infusion of 10-30 mg/kg/hr (maximum 1 gram/hr). * **Hypomagnesemia:** 25-50 mg/kg IV infusion over 1-4 hours. Higher doses may be needed, guided by serum magnesium levels and clinical status. Dosing in pediatrics requires careful calculation and frequent monitoring. Consult specific pediatric guidelines or institutional protocols. ## Dose Adjustments Dose adjustments are primarily based on renal function. Patients with impaired renal function may require reduced doses and increased monitoring of serum magnesium levels. Dialysis may remove magnesium. ## Contraindications * Hypermagnesemia * Heart block * Myocardial infarction (in the setting of acute MI, caution is advised) * Hypersensitivity to magnesium sulphate ## Adverse Effects * **Common:** Flushing, hypotension, nausea, vomiting, decreased deep tendon reflexes, lethargy, muscle weakness. * **Serious:** Respiratory depression, cardiac arrhythmias, coma, hypermagnesemia (especially with renal impairment). ## Key Drug Interactions * **Neuromuscular Blockers (e.g., succinylcholine, vecuronium):** Magnesium sulphate can potentiate neuromuscular blockade, leading to prolonged muscle weakness or respiratory depression. * **Calcium Channel Blockers:** Additive hypotensive effects. * **Antibiotics (e.g., tetracyclines, quinolones):** Magnesium may decrease the absorption of these drugs; administer them at least 2 hours before or 4-6 hours after magnesium. ## Monitoring * **Serum magnesium levels:** Essential, especially with repeated dosing or in patients with renal impairment. Therapeutic range is typically 4-7 mg/dL. * **Deep tendon reflexes:** Should be present. Loss of reflexes indicates rising magnesium levels. * **Respiratory rate:** Should be monitored for signs of depression. * **Blood pressure and heart rate:** For hypotension and cardiac effects. * **Urine output:** Indicator of renal function and hydration. ## Clinical Pearls * Magnesium sulphate administration can cause flushing and a sensation of warmth. * Monitor for signs of magnesium toxicity, particularly if renal function is impaired. * In eclampsia, continuous IV infusion is preferred for maintenance therapy. * IM administration is painful and requires deep injection. Procaine may be added to reduce pain. * For hypomagnesemia, the dose and rate of infusion should be adjusted based on serum magnesium levels and clinical symptoms. *** *Disclaimer: This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information, clinical guidelines, and institutional protocols before making any treatment decisions.*